- Home
- WHWK vs MBOT Comparison
WHWK vs MBOT Comparison
Compare WHWK & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHWK | MBOT |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | 22 | 22 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.8M | 166.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | WHWK | MBOT |
|---|---|---|
| Price | $3.39 | $2.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $7.50 |
| AVG Volume (30 Days) | 180.7K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.39 | $1.60 |
| 52 Week High | $4.40 | $4.62 |
Technical Indicators
Market Signals| Indicator | WHWK | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 58.06 |
| Support Level | $1.84 | $2.34 |
| Resistance Level | $3.79 | $2.79 |
| Average True Range (ATR) | 0.24 | 0.15 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 33.58 | 69.31 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.